Association of DAPT duration with bleeding and ischemic outcomes after percutaneous coronary intervention with drug-coated balloons: a meta-analysis

• by Giuseppe Panuccio, Nicole Carabetta, Martina Sportelli, Giuseppe Tartaglione, Kambis Mashayekhi, Emmanouil S. Brilakis, David M. Leistner, Sabato Sorrentino, Youssef Abdelwahed, Ulf Landmesser, Salvatore De Rosa, Daniele Torella

• May 18, 2026

PAHR: Prognostic Marker in Severe Aortic Stenosis?

Researchers evaluated whether a composite measure of heart rate and pressure could capture overall hemodynamic burden.

• by Julia Cipriano, MS, CMPP

• June 27, 2026

• 3 min

Correction: The effect of dapagliflozin on cardiorespiratory fitness in patients with coronary heart disease and type 2 diabetes mellitus following PCI: a single-center prospective randomized controlled study

• by Jiali Yang, Xinru Li, Liangqiu Tang, Wenmao Fan, Aihua Li, Wanming Zhou, Jungang Pang, Qiuxiao Yuan, Ming Zhong, Jinhui Hou, Lan Wang, Wenjiao Liao, Xiangyang Liu, BMC Cardiovascular

• June 2, 2026

Side Effects: Variety Is Overrated

The organ you forgot, the cells that age unevenly, the AI that admits ignorance, and the diet advice that sounds wrong but isn't: medicine's next moves are hiding in plain sight.

• by Kerri Miller

• March 30, 2026

• 7 min